Selected article for: "free energy and mutant antibody"

Author: Thomas Desautels; Adam Zemla; Edmond Lau; Magdalena Franco; Daniel Faissol
Title: Rapid in silico design of antibodies targeting SARS-CoV-2 using machine learning and supercomputing
  • Document date: 2020_4_10
  • ID: kg2j0dqy_28
    Snippet: The Supplementary Materials to this document include (1) the 10 homology-based structural models we developed of SARS-CoV-2 in complex with SARS-CoV-1 neutralizing antibodies and (2) all antibody mutant sequences and in silico free energy calculations performed for 89,263 mutant antibodies derived from the M396 SARS-CoV-1 neutralizing antibody, which we used to select a first round of 20 candidate antibodies for experimental evaluation......
    Document: The Supplementary Materials to this document include (1) the 10 homology-based structural models we developed of SARS-CoV-2 in complex with SARS-CoV-1 neutralizing antibodies and (2) all antibody mutant sequences and in silico free energy calculations performed for 89,263 mutant antibodies derived from the M396 SARS-CoV-1 neutralizing antibody, which we used to select a first round of 20 candidate antibodies for experimental evaluation.

    Search related documents:
    Co phrase search for related documents
    • antibody mutant sequence and mutant sequence: 1
    • antibody mutant sequence and neutralizing antibody: 1
    • antibody mutant sequence and SARS neutralizing antibody: 1
    • energy calculation and SARS develop: 1, 2, 3
    • experimental evaluation and neutralizing antibody: 1
    • mutant antibody and neutralize antibody: 1, 2
    • mutant antibody and neutralizing antibody: 1, 2, 3, 4, 5
    • mutant antibody and SARS develop: 1
    • mutant antibody and SARS neutralize antibody: 1
    • mutant antibody and SARS neutralizing antibody: 1, 2
    • mutant antibody and structural model: 1
    • mutant sequence and neutralizing antibody: 1
    • mutant sequence and SARS neutralizing antibody: 1
    • neutralize antibody and SARS develop: 1, 2
    • neutralize antibody and SARS neutralize antibody: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • neutralizing antibody and SARS develop: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44
    • neutralizing antibody and SARS neutralize antibody: 1, 2, 3
    • neutralizing antibody and SARS neutralizing antibody: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75
    • neutralizing antibody and structural model: 1, 2, 3